Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma

<div>The characteristics of immune infiltration in different risk groups. (a) Comparison of immune cell abundance in different risk groups according to CIBERSORT analysis. (b) Relationship between the risk score and the 29 immune signatures according to ssGSEA analysis. (c-d) Correlation between the risk score and immune-related scores. (e) The relationship between immune cell markers and the risk score.</div>

Genetics Research

fig4

Figure 4

Figure 4: Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma 

Figure 4 | Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma 